Core Viewpoint - Waystar Holding (WAY) has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Performance - The Zacks rating system emphasizes the importance of earnings estimate revisions, which are strongly correlated with near-term stock price movements [4][6]. - Waystar is projected to earn $1.39 per share for the fiscal year ending December 2025, with no year-over-year change, but the Zacks Consensus Estimate has increased by 3.1% over the past three months [8]. Investment Implications - The upgrade to Zacks Rank 2 places Waystar in the top 20% of Zacks-covered stocks, suggesting potential for market-beating returns in the near term [10]. - Rising earnings estimates and the corresponding rating upgrade reflect an improvement in Waystar's underlying business, which could lead to increased buying pressure and a higher stock price [5][10].

Core Insights - Waystar is addressing significant financial challenges in the healthcare sector, including $20 billion in denied claims and $17 billion in uncompensated care, by introducing AI-powered software innovations aimed at improving financial performance and resilience for healthcare providers [1][2]. Group 1: Financial Challenges - Healthcare providers are facing $20 billion annually in costs related to denied claims and $17 billion in uncompensated care due to lower patient collections [2]. - Eliminating manual steps in obtaining payer reimbursement could save the industry $2.6 billion [2]. Group 2: Waystar's Innovations - Waystar is launching the first scaled, AI-powered, end-to-end solution for denial appeals, significantly reducing the time required to create appeal packages from 38 hours to just 2 hours, which allows for a redeployment of resources [4]. - The new AI capabilities have enabled early adopters to overturn 40% more denials and improve pre-service patient payments from 17% to 40% of total payments, enhancing cash flow and reducing uncompensated care [5][4]. Group 3: Efficiency Gains - Waystar's platform delivers over 90% time savings across key capabilities, allowing healthcare providers to reclaim millions in revenue and free up resources equivalent to more than a dozen full-time employees [2]. - The AI technology reduces denial-prevention-related work from 133 hours to under 6 hours, achieving a 95% time savings [6]. Group 4: Market Position - Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, and processes over 6 billion healthcare payment transactions annually, including over $1.8 trillion in gross claims [8].

Core Viewpoint - Waystar Holding Corp. announced a secondary offering of 18,000,000 shares of common stock by certain investment funds, including EQT AB, Bain Capital, and Canada Pension Plan Investment Board, with J.P. Morgan acting as the underwriter [1][2]. Company Overview - Waystar is a provider of healthcare payments software, serving approximately 30,000 clients and over 1 million distinct providers, including 16 of the top 20 institutions on the U.S. News Best Hospitals list [5]. - The company's platform processes over 6 billion healthcare payment transactions annually, amounting to over $1.8 trillion in gross claims, covering approximately 50% of U.S. patients [5]. Offering Details - The shares will be offered to the public at a fixed price, which may change without notice, and Waystar will not receive any proceeds from this offering [2][3]. - A registration statement on Form S-3 has been filed with the SEC and has become effective, allowing the offering to proceed [3][4].

Core Viewpoint - The market anticipates Waystar Holding (WAY) to report a year-over-year increase in earnings driven by higher revenues in its upcoming earnings report for the quarter ended June 2025, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Waystar is expected to post quarterly earnings of $0.33 per share, reflecting a significant year-over-year increase of +725% [3]. - Revenues are projected to reach $254.09 million, marking an 8.3% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analyst expectations [4]. - The Most Accurate Estimate for Waystar is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +1.54%, suggesting a bullish outlook from analysts [11]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive Earnings ESP is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [9]. - Waystar currently holds a Zacks Rank of 3, which, along with the positive Earnings ESP, suggests a likelihood of beating the consensus EPS estimate [11]. Historical Performance - In the last reported quarter, Waystar met the expected earnings of $0.32 per share, resulting in no surprise [12]. - Over the past four quarters, Waystar has beaten consensus EPS estimates three times, indicating a generally favorable performance trend [13]. Conclusion - While Waystar is positioned as a compelling earnings-beat candidate, other factors may also influence stock performance post-earnings release [16].

Core Insights - Waystar has been recognized as the Best Overall Healthcare Payments Solutions Provider by MedTech Breakthrough for the fourth consecutive year, highlighting its leadership in the healthcare payments sector [1][3] - The company has launched Waystar AltitudeAI™, a suite of AI-powered capabilities, and introduced generative AI solutions, significantly improving operational efficiency by reducing denial appeal times by 70% and streamlining denial-prevention workflows from three days to three minutes [2] Company Achievements - Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 16 of the top 20 institutions on the U.S. News Best Hospitals list [5] - The company processes over 6 billion healthcare payment transactions annually, amounting to over $1.8 trillion in gross claims, covering approximately 50% of U.S. patients [5] - Waystar has received multiple accolades, including ranking as the 1 healthcare payments solution in eight out of 18 AI categories by Black Book Market Research™ and recognition by Best in KLAS® across two revenue cycle categories [3] Industry Context - The MedTech Breakthrough Awards program recognizes top companies and technologies in the digital health and medical technology markets, emphasizing innovation and excellence across various categories [4]

TABLE OF CONTENTS As filed with the U.S. Securities and Exchange Commission on March 22, 2024. FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Waystar Holding Corp. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) Registration No. 333-275004 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 4 TO 7373 (Primary Standard Industrial Classification Code Number) 84-2886542 (I.R.S. Emp ...